HLA-DRB1 and COVID-19: Using next‐generation sequencing (NGS), the authors reported a significant difference in the frequency of the HLA‐DRB1*04:01 allele between severe COVID‐19 patients and asymptomatic participants (5.1% vs. 16.7%).